A 12-page Executive Summary offering summary highlights for 22 Accountable Care Organizations and ACO solutions companies regarding their successes during the most recent MSSP performance year.
Vizient: Top 10 drugs by Total Spend Among Members
- Adalimumab (Humira)
- Rituximab (Rituxan)
- Infliximab (Remicade)
- Pembrolizumab (Keytruda)
- Etanercept (Enbrel)
- Ustekinumab (Stelara)
- Nivolumab (Opdivo)
- Pegfilgrastim (Neulasta)
- Alteplase (Activase
- Cathflo)
- Denosumab (Prolia
- Xgeva)
Source: Vizient, January 2020 - https://www.vizientinc.com/-/media/documents/sitecorepublishingdocuments/public…
ACO Performance Case Studies
*By signing up for this offer you agree to receive the Accountable Care bulletin and the HealthExecWire news release bulletin.
Accountable Care
Offerings
Value-Based Payments
Offerings
Analytics
Offerings
Population Health
Offerings
Payers & Providers
Offerings